The Journal of Pediatrics
Volume 150, Issue 2 , Pages 180-184.e1 , February 2007

Clinical and Laboratory Features, Hospital Course, and Outcome of Rocky Mountain Spotted Fever in Children

Presented in part at the Pediatric Academic Societies’ meeting, Washington, DC, May 14-17, 2005.

Received 27 February 2006 ,Revised 19 August 2006 ,Accepted 1 November 2006.

References 

  1. Raoult D, Roux V. Rickettsioses as paradigms of new or emerging infectious diseases. Clin Microbiol Rev. 1997;10:694–719
  2. Dalton MJ, Clarke MJ, Holman RC, Krebs JW, Fishbein DB, Olson JG, et al. National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg. 1995;52:405–413
  3. Treadwell TA, Holman RC, Clarke MJ, Krebs JW, Paddock CD, Childs JE. Rocky Mountain spotted fever in the United States, 1993-1996. Am J Trop Med Hyg. 2000;63:21–26
  4. Marshall GS, Stout GG, Jacobs RF, Schutze GE, Paxton H, Buckingham SC, et al. Antibodies reactive to Rickettsia rickettsii among children living in the southeast and south central regions of the United States. Arch Pediatr Adolesc Med. 2003;157:443–448
  5. Bradford WD, Hawkins HK. Rocky mountain spotted fever in childhood. Am J Dis Child. 1977;131:1228–1232
  6. Haynes RE, Sanders DY, Cramblett HG. Rocky Mountain spotted fever in children. J Pediatr. 1970;76:685–693
  7. Holman RC, Paddock CD, Curns AT, Krebs JW, McQuiston JH, Childs JE. Analysis of risk factors for fatal Rocky Mountain spotted fever: evidence for superiority of tetracyclines for therapy. J Infect Dis. 2001;184:1437–1444
  8. Hayden AM, Marshall GS. Rocky Mountain spotted fever at Kosair Children’s Hospital, 1990-2002. J Ky Med Assoc. 2004;102:209–214
  9. Helmick CG, Bernard KW, D’Angelo LJ. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis. 1984;150:480–488
  10. Kirk JL, Fine DP, Sexton DJ, Muchmore HG. Rocky Mountain spotted fever: a clinical review based on 48 confirmed cases, 1943-1986. Medicine. 1990;69:35–45
  11. Kirkland KB, Wilkinson WE, Sexton DJ. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin Infect Dis. 1995;20:1118–1121
  12. Hattwick MAW, Retailliau H, O’Brien RJ, Slutzker M, Fontaine RE, Hanson B. Fatal Rocky Mountain spotted fever. JAMA. 1978;240:1499–1503
  13. Conlon PJ, Procop GW, Fowler V, Eloubeidi MA, Smith SR, Sexton DJ. Predictors of prognosis and risk of acute renal failure in patients with Rocky Mountain spotted fever. Am J Med. 1996;101:621–626
  14. Harrell GT. Rocky Mountain spotted fever. Medicine. 1949;28:333–370
  15. Steigman AJ. Rocky Mountain spotted fever and the avoidance of sulfonamides. J Pediatr. 1977;91:163–164Letter
  16. Fishbein DB, Frontini MG, Giles R, Vernon LL. Fatal cases of Rocky Mountain spotted fever in the United States, 1981-1988. Ann N Y Acad Sci. 1990;590:246–247
  17. American Academy of Pediatrics. Rocky Mountain spotted fever. In:  Pickering LK,  Baker CJ,  Long SS,  McMillan JA editor. 2006 Red Book: Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006;p. 570–572
  18. Centers for Disease Control and Prevention. Diagnosis and management of tick-borne rickettsial diseases in the United States—Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis: a practical guide for physicians and other health care and public health professionals. MMWR. 2006;55(No. RR-4):1–28

 Dr Jacobs receives support from the Horace C. Cabe Foundation.No reprints available from authors.

PII: S0022-3476(06)01085-7

doi: 10.1016/j.jpeds.2006.11.023

The Journal of Pediatrics
Volume 150, Issue 2 , Pages 180-184.e1 , February 2007

Article Tools

* Image Usage & Resolution